Pipeline

Realizing the potential of Gene Writing

Focus Area

At Tessera, we are advancing our Gene Writing™ technology and proprietary LNP delivery system to alter the human genome 
and effect precise, durable therapeutic 
change to cure even the most challenging genetic diseases.

We envision a future where we can treat each disease at its source by designing the optimal Gene Writing system for a given disease and delivering therapeutic instructions to the necessary tissue.

  • In Vivo LNP Rewriting: Liver, Lung, HSC
  • In Vivo LNP Writing: Liver, Lung, T cells
  • Ex Vivo LVP Rewriting & Writing: T cells, Other immune cells
Meet the leaders of our Gene Writers
See our Leadership